Notice2024-12265
National Heart, Lung, and Blood Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 5, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 109 (Wednesday, June 5, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 109 (Wednesday, June 5, 2024)]
[Notices]
[Page 48182]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-12265]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications or contract proposals
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; K99/R00 MOSAIC-Maximizing Opportunities for
Scientific and Academic Independent Careers.
Date: July 8, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Rockledge I 6705 Rockledge
Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nawazish Ali Naqvi, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 208-Y, Bethesda, MD 20892, (301) 827-7911,
<a href="/cdn-cgi/l/email-protection#aec0cfd9cfd4c7ddc680c0cfdfd8c7eec0c7c680c9c1d8"><span class="__cf_email__" data-cfemail="157b7462746f7c667d3b7b7464637c557b7c7d3b727a63">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Multi-Ethnic Study in Atherosclerosis
(MESA).
Date: July 11, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sun Saret, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
208-S Bethesda, MD 20892, (301) 435-0270 <a href="/cdn-cgi/l/email-protection#6a191f0444190b180f1e2a040302440d051c"><span class="__cf_email__" data-cfemail="7407011a5a0715061100341a1d1c5a131b02">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Short Term Training Program.
Date: July 15, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael P. Reilly, Ph.D. Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 208-Z Bethesda, MD 20892, (301) 827-7975
<a href="/cdn-cgi/l/email-protection#e795828e8b8b9e8a97a7898f8b858ec9898e8fc9808891"><span class="__cf_email__" data-cfemail="2456414d48485d4954644a4c48464d0a4a4d4c0a434b52">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Physician Scientist Transition to
Independence in Blood Science Research (R00--Clinical Trial
Optional).
Date: July 17, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nawazish Ali Naqvi, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 208-Y Bethesda, MD 20892, (301) 827-7911
<a href="/cdn-cgi/l/email-protection#0b656a7c6a7162786325656a7a7d624b656263256c647d"><span class="__cf_email__" data-cfemail="127c736573687b617a3c7c7363647b527c7b7a3c757d64">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Catalyze Product Definition for Small
Molecules and Biologics.
Date: July 18, 2024.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rajiv Kumar, Ph.D., Branch Chief, Blood and
Vascular Branch Office of Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes of Health, 6705
Rockledge Drive, 208-W Bethesda, MD 20892, 301-827-4612
<a href="/cdn-cgi/l/email-protection#dba9bab1b2adf5b0aeb6baa99bb5b2b3f5bcb4ad"><span class="__cf_email__" data-cfemail="0476656e6d722a6f71696576446a6d6c2a636b72">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; R35 OIA Review.
Date: July 24-25, 2024.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street,
Bethesda, MD 20814 (Hybrid Meeting).
Contact Person: Kristen Page, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive,
Suite 209-B Bethesda, MD 20892, (301) 827-7953 <a href="/cdn-cgi/l/email-protection#d3b8a1baa0a7b6bdfda3b2b4b693bdbabbfdb4bca5"><span class="__cf_email__" data-cfemail="3358415a4047565d1d43525456735d5a5b1d545c45">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: May 30, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-12265 Filed 6-4-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 5, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.